Dr. Albert Park received a U01 grant entitled “A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants.”
Dr. Park is a leading researcher in the CMV virus. He was featured last year in an article for his research.